Shares in GMCR have dropped approximately 17% during the past month, but a debit call spread purchased on the stock during the first 30 minutes of the trading week indicates one strategist is positioning for the price of the underlying to rebound during the next four trading sessions. It looks like the trader purchased a 460-lot Oct 04 ’13 $74/$77.5 call spread for a net premium of $1.07 per contract. The spread makes money if shares in GMCR rally 2.5% over the current price of $73.25 to exceed the effective breakeven point at $75.07, and makes maximum potential profits of $2.43 per contract given a roughly 6.0% rally in the price of the underlying to $77.50 by expiration this weekend.
BMY – Bristol-Myers Squibb Co. – Shares in the drug maker are bucking the trend today, up as much as 0.75% during morning trading to $46.54, amid a down day for U.S. stocks.
Trading in BMY call options today indicates some traders are positioning for shares in the name to rally significantly in the next couple of months. The most active contracts by volume on Bristol-Myers are the Nov $50 strike calls, with around 5,000 lots in play against open interest of just 16 contracts. Time and sales data from this morning suggests most of the volume was purchased at an average premium of $0.29 each. Buyers of the $50 calls stand ready to profit at November expiration in the event that shares rally 8.0% to exceed an average breakeven point and fresh 52-week high of $50.29. Shares in Bristol-Myers traded up to $49.57 in June, the highest level in more than a decade.
This article will become free after 48 hours (see below for free content). To read the rest of this article now, along with Phil's live intra-day comments, live trading ideas, Phil's market calls, additional member comments, and other members-only features - Subscribe to Phil's Stock World by clicking here.
